Artificial intelligence has a long road ahead to reach the front lines of healthcare—but... Read more »
Austin—SparkCognition, a company that uses machine learning software to monitor clients’ infrastructure and technology for malfunctions and other problems, has boosted its Series B round of funding to $32.5 million. The round was led by Verizon Ventures, the venture capital... Read more »
Catch up on news from Wisconsin’s innovation community with these recent headlines:
—ARI Network Services (NASDAQ: ARIS), a Milwaukee-based company that develops e-commerce software for equipment manufacturers and other customers, was acquired for about $140 million by True Wind Capital,... Read more »
San Antonio—A Chinese pharmaceutical company is licensing two experimental drugs from two University of Texas research institutions for an initial $4.5 million upfront payment. The Texas institutions could receive more money if the drugs meet clinical and regulatory goals.
UT Health... Read more »
For the inaugural episode of our new podcast, Xconomy Voices, we chose to speak with Bay Area entrepreneur and executive Mary Lou Jepsen. She leads a startup called Openwater, which is developing a new kind of wearable imaging device... Read more »
It’s always been Xconomy’s mission to reach audiences—both here on our website, and at our many live events around the country—with deep insights into the innovation process, divined from experts embedded in the world’s most important hubs of high-tech entrepreneurship.
And... Read more »
Cloudbeds, a cloud-based provider of hospitality management software, said today it has raised slightly more than $9 million in Series B financing to expand its software-as-a-service platform and broaden awareness of its brand.
The San Diego company describes the financing as... Read more »
Although antibodies play a key role in neutralizing invading bacteria and viruses, sometimes these protective proteins can turn against the body’s own tissues, sparking an autoimmune disorder.
Syntimmune’s leaders believe their company has found a way to block the immune system’s... Read more »
In a prime example of the promise of artificial intelligence to improve human capabilities, rather than just replace them, Textio is bringing its “augmented writing” technology to e-mails, sales and marketing communications, and other forms of business writing, and just raised... Read more »
Professor of Systems Biology, Columbia University
Founder and CEO, Lighter Capital
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Managing Director, Mercury Fund
Chairman, CEO, & Founder, Alexandria Real Estate Equities